Pfizer and its partner BioNTech have finally released the results of clinical trials exploring whether their COVID-19 vaccine causes subclinical heart inflammation. The companies found that multiple vaccine recipients suffered heart-related symptoms, but said none met the definition of myocarditis, or heart inflammation. Researchers with the companies and other institutions analyzed the levels of troponin I, a sign of possible …